197 related articles for article (PubMed ID: 10868811)
1. Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals.
Angulo FJ; Johnson KR; Tauxe RV; Cohen ML
Microb Drug Resist; 2000; 6(1):77-83. PubMed ID: 10868811
[TBL] [Abstract][Full Text] [Related]
2. Public health consequences of use of antimicrobial agents in food animals in the United States.
Anderson AD; Nelson JM; Rossiter S; Angulo FJ
Microb Drug Resist; 2003; 9(4):373-9. PubMed ID: 15000744
[TBL] [Abstract][Full Text] [Related]
3. Nontyphoidal salmonellosis.
Hohmann EL
Clin Infect Dis; 2001 Jan; 32(2):263-9. PubMed ID: 11170916
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial therapy of salmonelloses--current state and perspectives.
Stoycheva MV; Murdjeva MA
Folia Med (Plovdiv); 2006; 48(1):5-10. PubMed ID: 16918048
[TBL] [Abstract][Full Text] [Related]
5. [Increase in antimicrobial resistance of Salmonella from food to fluoroquinolones and cephalosporins--a review of data from ten years].
Tenhagen BA; Schroeter A; Szabo I; Dorn C; Appel B; Helmuth R; Käsbohrer A
Berl Munch Tierarztl Wochenschr; 2014; 127(11-12):428-34. PubMed ID: 25872252
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations.
Varma JK; Molbak K; Barrett TJ; Beebe JL; Jones TF; Rabatsky-Ehr T; Smith KE; Vugia DJ; Chang HG; Angulo FJ
J Infect Dis; 2005 Feb; 191(4):554-61. PubMed ID: 15655779
[TBL] [Abstract][Full Text] [Related]
7. A nosocomial outbreak of fluoroquinolone-resistant salmonella infection.
Olsen SJ; DeBess EE; McGivern TE; Marano N; Eby T; Mauvais S; Balan VK; Zirnstein G; Cieslak PR; Angulo FJ
N Engl J Med; 2001 May; 344(21):1572-9. PubMed ID: 11372008
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Biedenbach DJ; Toleman M; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
[TBL] [Abstract][Full Text] [Related]
9. Nontyphoid salmonella infection: microbiology, clinical features, and antimicrobial therapy.
Chen HM; Wang Y; Su LH; Chiu CH
Pediatr Neonatol; 2013 Jun; 54(3):147-52. PubMed ID: 23597525
[TBL] [Abstract][Full Text] [Related]
10. Emerging quinolone-resistant Salmonella in the United States.
Herikstad H; Hayes P; Mokhtar M; Fracaro ML; Threlfall EJ; Angulo FJ
Emerg Infect Dis; 1997; 3(3):371-2. PubMed ID: 9284384
[TBL] [Abstract][Full Text] [Related]
11. Human health consequences of antimicrobial drug-resistant Salmonella and other foodborne pathogens.
Mølbak K
Clin Infect Dis; 2005 Dec; 41(11):1613-20. PubMed ID: 16267734
[TBL] [Abstract][Full Text] [Related]
12. Salmonella Infections in Childhood.
Bula-Rudas FJ; Rathore MH; Maraqa NF
Adv Pediatr; 2015 Aug; 62(1):29-58. PubMed ID: 26205108
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a national surveillance program for antimicrobial resistance in Salmonella.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Feb; 45(5):110-1. PubMed ID: 8592493
[No Abstract] [Full Text] [Related]
14. The US national antimicrobial resistance monitoring system.
Gilbert JM; White DG; McDermott PF
Future Microbiol; 2007 Oct; 2(5):493-500. PubMed ID: 17927472
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and mechanisms of quinolone resistance among selected nontyphoid Salmonella isolated from food animals and humans in Korea.
Tamang MD; Nam HM; Kim A; Lee HS; Kim TS; Kim MJ; Jang GC; Jung SC; Lim SK
Foodborne Pathog Dis; 2011 Nov; 8(11):1199-206. PubMed ID: 21877929
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000-2004: a report from the Enter-net International Surveillance Network.
Meakins S; Fisher IS; Berghold C; Gerner-Smidt P; Tschäpe H; Cormican M; Luzzi I; Schneider F; Wannett W; Coia J; Echeita A; Threlfall EJ;
Microb Drug Resist; 2008 Mar; 14(1):31-5. PubMed ID: 18366323
[TBL] [Abstract][Full Text] [Related]
17. Emergence of multidrug-resistant salmonella concord infections in Europe and the United States in children adopted from Ethiopia, 2003-2007.
Hendriksen RS; Mikoleit M; Kornschober C; Rickert RL; Duyne SV; Kjelsø C; Hasman H; Cormican M; Mevius D; Threlfall J; Angulo FJ; Aarestrup FM
Pediatr Infect Dis J; 2009 Sep; 28(9):814-8. PubMed ID: 19710587
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003).
Streit JM; Jones RN; Toleman MA; Stratchounski LS; Fritsche TR
Int J Antimicrob Agents; 2006 May; 27(5):367-75. PubMed ID: 16647842
[TBL] [Abstract][Full Text] [Related]
19. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis.
Chiu CH; Wu TL; Su LH; Chu C; Chia JH; Kuo AJ; Chien MS; Lin TY
N Engl J Med; 2002 Feb; 346(6):413-9. PubMed ID: 11832529
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of resistance to quinolones in Salmonella.
Bager F; Helmuth R
Vet Res; 2001; 32(3-4):285-90. PubMed ID: 11432419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
